{
    "topic": "healthcare",
    "source": "New York Times - News",
    "bias": 0,
    "url": "http://www.nytimes.com/2012/06/09/us/politics/e-mails-reveal-extent-of-obamas-deal-with-industry-on-health-care.html",
    "title": "Obama Was Pushed by Drug Industry, E-Mails Suggest",
    "date": "2012-06-09",
    "authors": "Peter Baker",
    "content": "But the bargain was one that the president deemed necessary to forestall industry opposition that had thwarted efforts to cover the uninsured for generations . Without the deal , in which the industry agreed to provide $ 80 billion to expand coverage in exchange for protection from policies that would cost more , Mr. Obama calculated he might get nowhere .\n\u201c Throughout his campaign , President Obama was clear that he would bring every stakeholder to the table in order to pass health reform , even longtime opponents like the pharmaceutical industry , \u201d Dan Pfeiffer , the White House communications director , said Friday . \u201c He understood correctly that the unwillingness to work with people on both sides of the issue was one of the reasons why it took a century to pass health reform . \u201d\nRepublicans see the deal as hypocritical . \u201c He said it was going to be the most open and honest and transparent administration ever and lobbyists won \u2019 t be drafting the bills , \u201d said Representative Michael C. Burgess of Texas , a Republican on the House Energy and Commerce Committee examining the deal . \u201c Then when it came time , the door closed , the lobbyists came in and the bills were written . \u201d\nSome liberals bothered by the deal in 2009 now find the Republican criticism hard to take given the party \u2019 s longstanding ties to the industry .\n\u201c Republicans trumpeting these e-mails is like a fox complaining someone else raided the chicken coop , \u201d said Robert Reich , who was labor secretary under President Bill Clinton . \u201c Sad to say , it \u2019 s called politics in an era when big corporations have an effective veto over major legislation affecting them and when the G.O.P . is usually the beneficiary . \u201d\nIn a statement , the Pharmaceutical Research and Manufacturers of America , the drug industry lobby known as PhRMA , called its interactions with the White House part of its mission to \u201c ensure patient access \u201d to high-quality medicine : \u201c Before , during and since the health care debate , PhRMA engaged with Congress and the administration to advance these priorities , \u201d the lobby statement said .\nIf the negotiations resembled deal-making by past presidents , what distinguished them was that Mr. Obama had strongly rejected business as usual . During his campaign , he singled out the power of the pharmaceutical industry and its chief lobbyist , former Representative Billy Tauzin , a Democrat-turned-Republican from Louisiana .\n\u201c The pharmaceutical industry wrote into the prescription drug plan that Medicare could not negotiate with drug companies , \u201d Mr. Obama said in a campaign advertisement , referring to 2003 legislation . \u201c And you know what ? The chairman of the committee who pushed the law through went to work for the pharmaceutical industry making $ 2 million a year . \u201d\nNewsletter Sign Up Continue reading the main story Please verify you 're not a robot by clicking the box . Invalid email address . Please re-enter . You must select a newsletter to subscribe to . Sign Up You will receive emails containing news content , updates and promotions from The New York Times . You may opt-out at any time . You agree to receive occasional updates and special offers for The New York Times 's products and services . Thank you for subscribing . An error has occurred . Please try again later . View all New York Times newsletters .\nMr. Obama continued : \u201c That \u2019 s an example of the same old game playing in Washington . You know , I don \u2019 t want to learn how to play the game better . I want to put an end to the game playing . \u201d\nThe e-mails document tumultuous negotiations , at certain times transactional , at others prickly . Each side suspected the other of operating in bad faith . Led by Rahm Emanuel , Mr. Obama \u2019 s chief of staff at the time , and Jim Messina , his deputy , the White House appeared deeply involved , and not averse to pressure tactics .\nIn May , the White House was upset industry had not signed on to a joint statement . One industry official urged colleagues to sign : \u201c Rahm is already furious . The ire will be turned on us. \u201d By June , tension flared again . \u201c Barack Obama is going to announce in his Saturday radio address support for rebating all of D unless we come to a deal , \u201d wrote Bryant Hall , a PhRMA lobbyist , referring to a Medicare Part D change that would cost the industry .\nA public confrontation was averted and an agreement announced , negotiated down to $ 80 billion from $ 100 billion . \u201c We got a good deal , \u201d Mr. Hall wrote .\nThe White House thought it did , too , and defended it against Democrats in Congress . \u201c WH is working on some very explicit language on importation to kill it in health care reform , \u201d Mr. Hall wrote in September .\nMr. Emanuel , now mayor of Chicago ; Mr. Messina , now the president \u2019 s campaign manager ; Ms. DeParle , now deputy White House chief of staff ; and Mr. Bryant , now heading his own firm , all declined to comment .\nThe e-mails released Friday also underscored detailed discussions about an advertising campaign supporting Mr. Obama \u2019 s health overhaul . \u201c They plan to hit up the \u2018 bad guys \u2019 for most of the $ , \u201d a union official wrote after an April meeting . \u201c They want us to just put in enough to be able to put our names in it \u2014 he is thinking @ 100K. \u201d In July , Mr. Hall wrote , \u201c Rahm asked for Harry and Louise ads thru third party , \u201d referring to the characters the industry had used to defeat Mr. Clinton \u2019 s health care proposal 15 years earlier .\nIndustry and Democratic officials said advertising was an outgrowth of the deal , not its goal . The industry traditionally advertises for legislation it supports .\nIn the end , balky House Democrats imposed additional conditions on the industry that pushed the cost above $ 100 billion , but the more sweeping policies it feared remained out of the legislation . Mr. Obama signed it in March 2010 . He had the victory he wanted .",
    "content_original": "But the bargain was one that the president deemed necessary to forestall industry opposition that had thwarted efforts to cover the uninsured for generations. Without the deal, in which the industry agreed to provide $80 billion to expand coverage in exchange for protection from policies that would cost more, Mr. Obama calculated he might get nowhere.\n\n\u201cThroughout his campaign, President Obama was clear that he would bring every stakeholder to the table in order to pass health reform, even longtime opponents like the pharmaceutical industry,\u201d Dan Pfeiffer , the White House communications director, said Friday. \u201cHe understood correctly that the unwillingness to work with people on both sides of the issue was one of the reasons why it took a century to pass health reform.\u201d\n\nRepublicans see the deal as hypocritical. \u201cHe said it was going to be the most open and honest and transparent administration ever and lobbyists won\u2019t be drafting the bills,\u201d said Representative Michael C. Burgess of Texas , a Republican on the House Energy and Commerce Committee examining the deal. \u201cThen when it came time, the door closed, the lobbyists came in and the bills were written.\u201d\n\nSome liberals bothered by the deal in 2009 now find the Republican criticism hard to take given the party\u2019s longstanding ties to the industry.\n\n\u201cRepublicans trumpeting these e-mails is like a fox complaining someone else raided the chicken coop,\u201d said Robert Reich , who was labor secretary under President Bill Clinton . \u201cSad to say, it\u2019s called politics in an era when big corporations have an effective veto over major legislation affecting them and when the G.O.P. is usually the beneficiary.\u201d\n\nPhoto\n\nIn a statement, the Pharmaceutical Research and Manufacturers of America, the drug industry lobby known as PhRMA, called its interactions with the White House part of its mission to \u201censure patient access\u201d to high-quality medicine: \u201cBefore, during and since the health care debate, PhRMA engaged with Congress and the administration to advance these priorities,\u201d the lobby statement said.\n\nIf the negotiations resembled deal-making by past presidents, what distinguished them was that Mr. Obama had strongly rejected business as usual. During his campaign, he singled out the power of the pharmaceutical industry and its chief lobbyist, former Representative Billy Tauzin , a Democrat-turned-Republican from Louisiana .\n\nAdvertisement Continue reading the main story\n\n\u201cThe pharmaceutical industry wrote into the prescription drug plan that Medicare could not negotiate with drug companies,\u201d Mr. Obama said in a campaign advertisement, referring to 2003 legislation. \u201cAnd you know what? The chairman of the committee who pushed the law through went to work for the pharmaceutical industry making $2 million a year.\u201d\n\nNewsletter Sign Up Continue reading the main story Please verify you're not a robot by clicking the box. Invalid email address. Please re-enter. You must select a newsletter to subscribe to. Sign Up You will receive emails containing news content , updates and promotions from The New York Times. You may opt-out at any time. You agree to receive occasional updates and special offers for The New York Times's products and services. Thank you for subscribing. An error has occurred. Please try again later. View all New York Times newsletters.\n\nMr. Obama continued: \u201cThat\u2019s an example of the same old game playing in Washington. You know, I don\u2019t want to learn how to play the game better. I want to put an end to the game playing.\u201d\n\nThe e-mails document tumultuous negotiations, at certain times transactional, at others prickly. Each side suspected the other of operating in bad faith. Led by Rahm Emanuel , Mr. Obama\u2019s chief of staff at the time, and Jim Messina, his deputy, the White House appeared deeply involved, and not averse to pressure tactics.\n\nIn May, the White House was upset industry had not signed on to a joint statement. One industry official urged colleagues to sign: \u201cRahm is already furious. The ire will be turned on us.\u201d By June, tension flared again. \u201c Barack Obama is going to announce in his Saturday radio address support for rebating all of D unless we come to a deal,\u201d wrote Bryant Hall, a PhRMA lobbyist, referring to a Medicare Part D change that would cost the industry.\n\nA public confrontation was averted and an agreement announced, negotiated down to $80 billion from $100 billion. \u201cWe got a good deal,\u201d Mr. Hall wrote.\n\nThe White House thought it did, too, and defended it against Democrats in Congress. \u201cWH is working on some very explicit language on importation to kill it in health care reform,\u201d Mr. Hall wrote in September.\n\nMr. Emanuel, now mayor of Chicago ; Mr. Messina, now the president\u2019s campaign manager; Ms. DeParle, now deputy White House chief of staff; and Mr. Bryant, now heading his own firm, all declined to comment.\n\nThe e-mails released Friday also underscored detailed discussions about an advertising campaign supporting Mr. Obama\u2019s health overhaul. \u201cThey plan to hit up the \u2018bad guys\u2019 for most of the $,\u201d a union official wrote after an April meeting. \u201cThey want us to just put in enough to be able to put our names in it \u2014 he is thinking @100K.\u201d In July, Mr. Hall wrote, \u201cRahm asked for Harry and Louise ads thru third party,\u201d referring to the characters the industry had used to defeat Mr. Clinton\u2019s health care proposal 15 years earlier.\n\nIndustry and Democratic officials said advertising was an outgrowth of the deal, not its goal. The industry traditionally advertises for legislation it supports.\n\nIn the end, balky House Democrats imposed additional conditions on the industry that pushed the cost above $100 billion, but the more sweeping policies it feared remained out of the legislation. Mr. Obama signed it in March 2010. He had the victory he wanted.",
    "source_url": "www.nytimes.com",
    "bias_text": "left",
    "ID": "3ZZDo3HQPGIksVIJ"
}